With greater knowledge of the processes involved in platelet aggregation, it has become clear that these are important not only in thrombus formation but also in inflammatory and immunologic reactions. The therapeutic implications may be far-reaching: Certain drugs have already been shown to inhibit the release of platelet constituents following aggregation in response to injury.